MagicTouch AVF - Treatment of Dysfunctional Arteriovenous Fistula & Graft
MagicTouch AVF - Concept Medical - Developing technologies for drug delivery with a strong emphasis on intellectual property.

A functioning dialysis access (AVF/AVG) is critical to the delivery of life saving hemodialysis therapy in patients with End Stage Renal Failure

PROMISING REVASCULARIZATION THERAPY FOR DYSFUNCTIONAL DIALYSIS FISTULA

MagicTouch AVF is intended for stenotic lesions of dysfunctional arteriovenous fistula and graft

Sirolimus Coated

Balloon Catheter

MagicTouch AVF

Assuring Safety by Delivering Sirolimus

  • TECHNOLOGY - MagicTouch AVF

    TECHNOLOGY

    An innovative proprietary Nanolute technology providing better bioavailability of SIROLIMUS

  • COATING - MagicTouch AVF

    COATING

    Unique coating technology leads to 100% balloon surface coating

  • DRUG - MagicTouch AVF

    DRUG

    Sirolimus: A drug with proven safety profile

  • CARRIER - MagicTouch AVF

    CARRIER

    A biocompatible phospholipid drug carrier improving the adhesion property of Sirolimus

Nanolute Technology

NANOLUTE TECHNOLOGY is designed to improve the lipophilicity and bioavailability of Sirolimus

  • Phospholipid is a drug carrier with two lipophilic tails and one hydrophilic head.
  • Sirolimus is encapsulated in phospholipid with proprietary Nanolute technology.

Know More

Unique Coating Technology

Drug carrier along with drug is coated on the unfolded balloon to achieve 100% coating on balloon surface
Unique and proprietary refolding mechanism facilitates better crossing profile

TECHNICAL SPECIFICATION

DrugSirolimus
Drug Dose1.27 µg/mm2
Balloon Folding3 & 6 folds
Balloon ComplianceSemi-Compliant
Sheath Compatibility6F to 8F
Guiding Catheter Compatibility7F to 9F
Balloon Diameter (mm)3.00, 4.00, 5.00, 6.00, 7.00, 8.00, 9.00, 10.00, 12.00
Balloon Length (mm)20, 40, 60, 80, 100, 120, 150, 200
Catheter Shaft Length (cm)45, 80, 90, 130, 150
Guide Wire Compatibility0.035’’ OTW

ORDERING INFORMATION

Diameter/Length20 mm40 mm60 mm80 mm100 mm
3.00 mmCMFW35001CMFW35002CMFW35003CMFW35004
4.00 mmCMFW35005CMFW35006CMFW35007CMFW35008CMFW35009
5.00 mmCMFW35010CMFW35011CMFW35012CMFW35013CMFW35014
6.00 mmCMFW35015CMFW35016CMFW35017CMFW35018CMFW35019
7.00 mmCMFW35020CMFW35021CMFW35022CMFW35023CMFW35024
8.00 mmCMFW35025CMFW35026CMFW35027CMFW35028CMFW35029
9.00 mmCMFW35030CMFW35031CMFW35032CMFW35033
10.00 mmCMFW35034CMFW35035CMFW35036CMFW35037
12.00 mmCMFW35038CMFW35039CMFW35040CMFW35041

Talk to a representative
Fill out a quick form and our representatives will be in touch.


MagicTouch AVF

Clinical Programmes

Sr. NoStudy NameType of StudyTarget PatientsCountryClinical Trials Identifier
Sr. No:  1Study Name:   MAGICTOUCH AVF IN SALVAGE OF AVG Type of Study:  Observational, Prospective, All comers, real-world RegistryTarget Patients:  20Country:  SingaporeClinical Trials Identifier:  https://clinicaltrials.gov/ct2/show/NCT03666208
Sr. No:  2Study Name:   MATILDA Type of Study:  Target Patients:  33Country:  SingaporeClinical Trials Identifier:  https://clinicaltrials.gov/ct2/show/NCT04698512
Sr. No:  3Study Name:   IMPRESSION Type of Study:  Target Patients:  170Country:  SingaporeClinical Trials Identifier:  https://clinicaltrials.gov/ct2/show/NCT04409912
Sr. No:  4Study Name:   Magic Touch AVF – US FDA Type of Study:  Target Patients:  376Country:  Clinical Trials Identifier:  
Sr. No:  5Study Name:   PAVE 2 Type of Study:  Target Patients:  642Country:  UKClinical Trials Identifier:  
“Confidence Through Evidence”
Get in Touch